<DOC>
	<DOCNO>NCT01580839</DOCNO>
	<brief_summary>The primary hypothesis test trial ischaemic stroke patient select significant penumbral mismatch ( accord image criterion ) 4.5 ( 3 hour depend local guideline ) - 9 hour post onset stroke 'wake stroke ' ( WUS ) improve clinical outcome give intravenous tissue plasminogen activator ( tPA ) compare placebo .</brief_summary>
	<brief_title>EXTEND ( International ) : Extending Time Thrombolysis Emergency Neurological Deficits ( International )</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Patients present hemispheric acute ischaemic stroke Patient , family member legally responsible person depend local ethic requirement give informed consent Patient 's age ≥18 year ( per local requirement ) Treatment onset commence within 4.5 9 hour stroke onset accord registered product information , within 3 9 hour accord locally accept guideline . Patients wake stroke may include neurological exclusion criterion satisfy . These 'wake ' stroke define symptom sleep onset , stroke symptom wake . The time stroke onset take midpoint sleep onset ( last know normal ) time wake . The maximum time window randomisation 9 hour midpoint describe . Significant neurological deficit ( eg . NIHSS score ≥ 4 26 ) clinical sign hemispheric infarction . Penumbral mismatch A `` hypoperfusion core '' volume ratio great 1.2 , absolute difference great 10ml ( use Magnetic Resonance ( MR ) Computed Tomography ( CT ) Tmax &gt; 6 second delay ) , perfusion lesion MRDWI Computed TomographyCerebral Blood Flow ( CTCBF ) core lesion . An infarct core lesion less equal 70ml use MRDWI CTCBF Intracranial haemorrhage ( ICH ) identify CT MRI Rapidly improve symptom , particularly judgment manage clinician improvement likely result patient NIHSS score &lt; 4 randomization Prestroke MRS score ≥ 2 ( indicate previous disability ) Contra indication image contrast agent Infarct core &gt; 1/3 Middle Cerebral Artery ( MCA ) territory qualitatively Participation investigational study previous 30 day Any terminal illness patient would expect survive 1 year Any condition could impose hazard patient study therapy initiate affect participation patient study ( applies patient severe microangiopathy haemolytic uremic syndrome thrombotic thrombocytopenic purpura ) . The judgment leave discretion Investigator . Pregnant woman ( clinically evident ) Previous stroke within last three month Recent past history clinical presentation ICH , subarachnoid haemorrhage ( SAH ) , arteriovenous ( AV ) malformation , aneurysm , cerebral neoplasm . At discretion Investigator . Current use oral anticoagulant prolong prothrombin time ( INR &gt; 1.6 ) Use heparin , except low dose subcutaneous heparin , previous 48 hour prolong activate thromboplastin time exceed upper limit local laboratory normal range . Use glycoprotein IIb IIIa inhibitor within past 72 hour . Use single dual agent oral platelet inhibitor ( clopidogrel and/or lowdose aspirin ) prior study entry permit . Clinically significant hypoglycaemia . Uncontrolled hypertension define blood pressure &gt; 185 mmHg systolic &gt; 110 mmHg diastolic least 2 separate occasion least 10 minute apart , require aggressive treatment reduce blood pressure within limit . The definition `` aggressive treatment '' leave discretion responsible Investigator . Hereditary acquire haemorrhagic diathesis Gastrointestinal urinary bleeding within precede 21 day Major surgery within precede 14 day pose risk opinion investigator . Exposure thrombolytic agent within previous 72 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>ischemic penumbra</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>MRI</keyword>
	<keyword>diffusion image</keyword>
	<keyword>DWI</keyword>
	<keyword>perfusion image</keyword>
	<keyword>PWI</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>alteplase</keyword>
	<keyword>tPA</keyword>
	<keyword>EPITHET</keyword>
</DOC>